Pathophysiology, Pharmacology and Biochemistry of Dyskinesia

· ·
· International Review of Neurobiology Libri 98 · Academic Press
Libër elektronik
664
Faqe
I përshtatshëm
Vlerësimet dhe komentet nuk janë të verifikuara  Mëso më shumë

Rreth këtij libri elektronik

Published since 1959, International Review of Neurobiology is a well-known series appealing to neuroscientists, clinicians, psychologists, physiologists, and pharmacologists. Led by an internationally renowned editorial board, this important serial publishes both eclectic volumes made up of timely reviews and thematic volumes that focus on recent progress in a specific area of neurobiology research. This volume reviews existing theories and current research surrounding the movement disorder Dyskinesia. - Leading authors review state-of-the-art in their field of investigation and provide their views and perspectives for future research - Chapters are extensively referenced to provide readers with a comprehensive list of resources on the topics covered - All chapters include comprehensive background information and are written in a clear form that is also accessible to the non-specialist

Rreth autorit

Professor Peter Jenner is a specialist in preclinical aspects of neurodegenerative diseases, notably Parkinson’s disease. He has spent the major part of his career at King’s College London where he was Head of Pharmacology for 14 years before returning to his research roots and subsequently becoming Emeritus Professor of Pharmacology. Peter has expertise in drug metabolism and pharmacokinetics but neuropharmacology based on functional models of neurodegenerative diseases has formed the major focus of his work. Peter holds a BPharm, PhD and DSc degree from the University of London. He has published well over 1000 articles with more than 700 peer reviewed papers. He is a Fellow of the Royal Pharmaceutical Society, the British Pharmacological Society, the Royal Society of Medicine and of King’s College London. Peter was recently honoured with a Doctor Honoris Causa degree from Carol Davila University of Medicine and Pharmacy, Bucharest and made an Honorary Fellow of The British Pharmacological Society for his contribution to research in to movement disorders.Peter has worked closely with the pharmaceutical industry for many years and acts as an adviser and consultant to both major pharma and biotech companies. He has a wide knowledge of the drug discovery and drug development process and has been involved from molecule synthesis through to drug registration for use in man. Peter was the Founder, Director and Chief Scientific Officer of Proximagen, a biotech focussed on the treatment and cure of neurodegenerative diseases that was listed on AIMs and subsequently purchased by a US based healthcare company. He is a regular speaker at international meetings and also takes time to speak at Parkinson’s disease patient-carer groups across the UK.

Vlerëso këtë libër elektronik

Na trego se çfarë mendon.

Informacione për leximin

Telefona inteligjentë dhe tabletë
Instalo aplikacionin "Librat e Google Play" për Android dhe iPad/iPhone. Ai sinkronizohet automatikisht me llogarinë tënde dhe të lejon të lexosh online dhe offline kudo që të ndodhesh.
Laptopë dhe kompjuterë
Mund të dëgjosh librat me audio të blerë në Google Play duke përdorur shfletuesin e uebit të kompjuterit.
Lexuesit elektronikë dhe pajisjet e tjera
Për të lexuar në pajisjet me bojë elektronike si p.sh. lexuesit e librave elektronikë Kobo, do të të duhet të shkarkosh një skedar dhe ta transferosh atë te pajisja jote. Ndiq udhëzimet e detajuara në Qendrën e ndihmës për të transferuar skedarët te lexuesit e mbështetur të librave elektronikë.